Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2001-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2003-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2003526662-A |
titleOfInvention |
Method for controlling hepatitis virus infection using immunomodulatory polynucleotide sequence |
abstract |
(57) [Summary]nMethods for treating hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are provided. A polynucleotide comprising an immune activating sequence is administered to an individual who has been exposed to or infected with HBV and / or HCV. The polynucleotide is not administered with an HCV or HBV antigen. Administration of the polynucleotide results in amelioration of symptoms of HBV and / or HCV infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007139190-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592566-B2 |
priorityDate |
2000-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |